This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Rajneesh Ramesh Shrivastava: Innovator in Pharmaceutical Compositions
Introduction
Rajneesh Ramesh Shrivastava is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions of curcumin. His work focuses on enhancing the bioavailability of curcumin, a compound known for its therapeutic properties.
Latest Patents
Rajneesh holds a patent for "Pharmaceutical compositions of curcumin." This invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or derivatives. The innovation boasts a higher concentration of curcumin and improved bioavailability without the use of buffers or molecular aggregation inhibitors. The curcumin is presented in a solubilized form, ensuring the stability of the liquid pharmaceutical composition.
Career Highlights
Rajneesh is currently associated with Cadila Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Cadila Pharmaceuticals has allowed him to focus on innovative solutions that address various health challenges.
Collaborations
Rajneesh has collaborated with notable colleagues, including Bakulesh Mafatlal Khamar and Ashish Premkumar Gogia. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Rajneesh Ramesh Shrivastava is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the medical field significantly. His innovative approach to curcumin formulations exemplifies the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
